Article Details
Retrieved on: 2024-02-23 14:38:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
Dr. Hans Keirstead, chairman of Immunis, Inc., will present at the Brain Trust Conference, emphasizing artificial intelligence and innovation in biotechnology, including the company's secretome-based therapies currently in clinical trials. The discussion aligns with proteomics and secretome research, with forward-looking statements concerning clinical outcomes.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here